progression of degenerative diseases associated with ageing are also discussed.
The proteostasis network
Maintaining a balanced proteome requires cells to coordinate the functions of three interlinked arms of the proteostasis network: protein synthesis and folding, conformational maintenance and degradation (Fig. 1a) .
Protein synthesis and folding. The proteomes of eukaryotic cells are highly complex, ranging from ~6,000 different proteins in fungi 5 to more than 10,000 proteins in human cells 6 , with proteome composition varying between cell types and tissues. Recent large-scale sequencing data indicate the presence of a high number of single nucleotide variants in protein-coding regions in the human population 7 . Mutations can affect protein stability and folding kinetics 8 , possibly resulting in metastable proteins that engage components of the proteostasis network 9, 10 . Proteins also vary greatly in abundance, from fewer than 50 copies per cell in the case of certain transcription factors to more than 10 million molecules for histones and cytoskeletal or ribosomal proteins 11, 12 . Protein abundance must be carefully controlled to support cell signalling and the proper flux of substrates through metabolic pathways and to allow the stoichiometric assembly of large macromolecular machines, such as ribosomes or mitochondrial respiratory chain complexes.
The majority of newly synthesized proteins must fold into defined 3D structures to attain biological function, with the notable exception of proteins with intrinsically disordered regions that may acquire structure only when interacting with partner molecules 13, 14 . Fig. 1 | The proteostasis network prevents the formation of toxic aggregates. a | The proteostasis network contains all the factors that are necessary to control the functional levels of proteins in their native state and minimize non-productive or harmful off-pathway reactions (generation of unfolded proteins or aggregates; red). Proteostasis network components, which comprise ~2,000 proteins in human cells, can be operationally assigned to three major arms: protein synthesis and folding (green), conformational maintenance (blue) and degradation (purple). In humans, ~300 different molecular chaperones 175 orchestrate these processes and function in folding, refolding and disaggregation reactions. They cooperate with the ubiquitin-proteasome system and the autophagosomal-lysosomal machinery in the degradation of misfolded proteins and aggregates. b | Proteins sample diverse conformations during folding, increasingly forming native intramolecular contacts as they progress downhill along a rugged energy landscape towards the thermodynamically stable, native state. Folding intermediates and misfolded states may accumulate as kinetically trapped species that need to traverse free-energy barriers to form functional proteins. Intermolecular contacts between non-native states may result in the formation of various aggregate species, including oligomers, amorphous aggregates and amyloid fibrils, the latter of which may even be thermodynamically more stable than the native state. Molecular chaperones enhance on-pathway reactions that support progression of folding intermediates towards the native state and block off-pathway reactions that lead to misfolded and aggregated species. Various factors, such as mutations, stress, translation aberrations or defects in mRNA , inhibit the on-pathway reactions, favouring protein misfolding and aggregation.
Generally, the folded (or native) states of proteins are thermodynamically favourable, and all the information necessary for folding is contained within the amino acid sequence of the newly synthesized polypeptide chain. However, proteins must navigate a complex energy landscape during folding, putting them at risk of adopting kinetically stable (meaning populating local energy minima) non-native structures (Fig. 1b) . These misfolded states also tend to engage in non-productive intermolecular interactions, forming aggregates that may be thermodynamically more stable than the native state. While the folding process was originally thought to occur spontaneously, we now know that many proteins, especially those with more complex structures and/or containing multiple domains, require molecular chaperones to fold efficiently and at a biologically relevant timescale. We define a molecular chaperone as any factor that interacts with and aids in the folding or assembly of another protein without being part of its final structure 15 . Mechanistically, chaperones prevent aggregation and promote folding through ATP-dependent and independent mechanisms of protein binding and release (recently reviewed elsewhere [16] [17] [18] [19] [20] ). They are classified into different protein families -small heat shock proteins (sHSPs), HSP60, HSP70 and HSP90 (Table 1) and typically recognize exposed hydrophobic amino acid residues and unstructured polypeptide backbones in their substrate proteins, which are unifying features of non-native conformations. In some cases, electrostatic interactions between chaperones and clients also have a role 21, 22 . Chaperones that participate broadly in the folding of newly synthesized proteins (de novo folding) act during and after translation to prevent (or reverse) misfolding and aggregation (Fig. 1) .
Approximately two-thirds of proteins must be transported from their site of synthesis in the cytosol to their functional location in a specific subcellular compartment 23 . For proteins destined for the endoplasmic reticulum (ER) and further for the secretory pathway, or for the mitochondria, cytosolic chaperones prevent 
Major chaperone family , comprising at least eight homologous chaperone proteins, located in the cytoplasm, mitochondria and the endoplasmic reticulum. These chaperones are required for aggregation prevention, folding of newly synthesized proteins and conformational maintenance. They also cooperate with HSP40 and HSP110 in protein disaggregation HSP40 (also known as J proteins)
• ~40 kDa A diverse group of proteins, all containing the HSP70-interacting J domain, with homologues in the cytoplasm, mitochondria and the endoplasmic reticulum. They function as co-chaperones of HSP70 and regulators of the HSP70 ATPase cycle of protein substrate binding and release. They recruit HSP70 to different substrates and cellular locations HSP110
• ~100 kDa Serves as a nucleotide exchange factor for HSP70. Cooperates with HSP70 in protein folding and degradation of misfolded proteins, and it is crucial for protein disaggregation in metazoans
Functions as a homodimer in the folding and conformational regulation of functionally and structurally diverse client proteins that are involved in many different cellular pathways. Major substrate classes are kinases, steroid receptor molecules and other signalling proteins. Cooperates with multiple co-chaperones containing TPR domains
The chaperonin of mitochondria. Consists of two heptameric rings composed of ~60 kDa subunits, which are stacked back-to-back. Cooperates with a cofactor, HSP10, and is required for the folding of a subset of mitochondrial proteins following their import from the cytosol
The chaperonin of the eukaryotic cytosol. Consists of two octameric rings composed of ~60 kDa subunits, which are stacked back-to-back. Required for the folding of a subset of cytosolic proteins, including actin and tubulins. TRiC has also been shown to interfere with the aggregation of huntingtin Hsp100
• ~100 kDa subunit • ATP-dependent A family of proteins in fungi, bacteria and chloroplasts in plants (comprising Hsp104, Hsp78, ClpA , ClpB, ClpC, ClpX and HsIU) that belongs to a large superfamily of AAA + ATPases. These chaperones are typically composed of hexameric rings. Hsp104 in yeast and other fungi mediates protein disaggregation in cooperation with Hsp70 and Hsp40
Small heat shock proteins
• ~12-45 kDa subunit ATP-independent chaperones that form large (~1 MDa) heterogeneous oligomers. Subunits contain a conserved α-crystallin domain, which is packed with β-sheets and involved in oligomerization. Ten different forms are present in humans (HSPB1-HSPB10). Prevent aggregation by binding to non-native states ('holdase' function) but also mediate sequestration of misfolded proteins into less-toxic aggregates HSP, heat shock protein; TPR , tetratricopeptide repeat.
NATuRe RevIewS | MoleCulaR Cell BIology premature folding before the polypeptide reaches its target organelle and shield transmembrane regions from the aqueous cytosol 18, 24 . Binding of organellar chaperones at the trans-side of the target membrane may then provide the driving force for translocation across the membrane 25, 26 . Proteins destined for the nucleus and peroxisomes and so-called tail-anchored proteins fold before transport.
Maintenance of conformational stability. The folded structures of proteins are, in most cases, only marginally stable. This implies that a substantial proportion of protein species may populate (partially) unfolded states (Fig. 1b) , especially in the presence of additional destabilizing factors, such as mutations or external stresses (for example, elevated temperature, heavy metals or the presence of reactive oxygen species). Polypeptides in nonnative conformations, including nascent chains, folding intermediates and misfolded states, tend to aggregate owing to the exposure of hydrophobic amino acid residues and unpaired β-strands. Aggregation removes proteins from the pool of functionally active molecules and thereby leads to a reduction of function of the aggregated protein. Moreover, aggregate species may be cytotoxic in a manner unrelated to their biological role, as discussed below.
To avoid the accumulation of misfolded proteins and cytotoxic protein aggregation, the proteostasis network contains molecular chaperones, for many of which transcription is induced under stress conditions through compartment-specific signalling pathways. The main cytosolic response to stress is the heat shock response, which is controlled by a group of transcription factors known as heat shock factors. By binding to heat shock elements in promoter regions, these factors control various genes encoding chaperones (heat shock proteins) and other factors of the proteostasis network. The best studied of these is heat shock factor 1 (HSF1). In nonstressed cells, HSF1 is present in an inactive complex with the chaperones HSP90 (ReF. 27 ) and HSP70 (ReF. 28 ).
The presence of non-native proteins is thought to result in titration of these chaperones away from HSF1, which then enables HSF1 to trimerize and induce the transcription of genes that encode heat shock proteins 29 . Concomitantly with the induction of members of the proteostasis network, general protein synthesis is attenuated upon stress, which reduces the production of new clients of the proteostasis network. Once the proteotoxic stress has ceased and sufficient free chaperone capacity is re-established, these factors rebind HSF1, and the system returns to balance 30 . Similar signalling pathways to counter aberrantly folded and/or unfolded proteins are present in the ER and in mitochondria 31, 32 . With few exceptions, homologues of stress-inducible chaperones are also constitutively expressed both in the cytosol and within organelles, including the heat shock protein families mentioned above 16, 18 . They form cooperative networks to maintain non-native protein species in solution and mediate their refolding to achieve functional structures (remodelling; Fig. 1a) . A distinct set of chaperones function in the conformational maintenance of the secreted proteome in the extracellular space 33 .
Tail-anchored proteins
Membrane proteins that are post-translationally inserted into the membrane. They can contain a transmembrane sequence near the carboxy terminus.
E3 ubiquitin ligase
an enzyme that mediates the transfer of ubiquitin from an e2 ubiquitin-conjugating enzyme to a protein substrate.
E2 ubiquitin-conjugating enzyme
an enzyme that catalyses the second step in the enzymatic cascade for the transfer of ubiquitin to protein substrates.
Reticulocytes
immature red blood cells.
Co-chaperone a factor that assists or regulates the function of a molecular chaperone; some co-chaperones also have chaperone activity in binding non-native proteins.
Chaperone-assisted selective autophagy a degradation pathway of chaperone-bound proteins in lysosomes.
Chaperone-mediated autophagy a chaperone-dependent degradation pathway of soluble cytosolic proteins that involves translocation of the substrate protein across the lysosomal membrane.
Endosomal microautophagy
Degradation of cytosolic proteins by late endosomes and/or multivesicular bodies.
Protein degradation. In combination with controlled protein synthesis, regulated degradation of proteins is an important mechanism to adjust the levels of functional proteins, thereby regulating important cellular processes such as mitosis 34 and adapting protein levels in response to environmental changes 35, 36 . Protein degradation is also a key mechanism to avoid accumulation of misfolded or faulty protein species, including mutant proteins and unassembled subunits of multiprotein complexes. Proteins are degraded by two major proteolytic pathways, the ubiquitin-proteasome system (UPS) and the autophagosomal-lysosomal pathway [37] [38] [39] . While degradation by the UPS requires ATP-dependent unfolding of single substrate proteins, the autophagy pathway enables the degradation of protein aggregates and whole organelles. In both proteolytic systems, molecular chaperones cooperate in the recognition of misfolded protein species and help to maintain them in a degradation-competent state [40] [41] [42] . In targeting aberrant proteins for degradation, the UPS cooperates with the major cytosolic chaperone systems, HSP70 and HSP90, and with chaperone cofactors containing e3 ubiquitin ligase activity, such as the carboxy terminus of HSP70-interacting protein (CHIP). CHIP interacts via its tetratricopeptide repeat (TPR) domain with the carboxy terminus of HSP70 or HSP90 to ubiquitylate folding-incompetent proteins -characterized by a long chaperone residence time 43 -which targets them to the proteasome. In addition, CHIP has the ability to prevent aggregation in the absence of these chaperones 44 . Other components of the UPS, the yeast E3 ligase San1 and the metazoan e2 ubiquitinconjugating enzyme UBE2O also have inbuilt chaperone properties and bind surplus or misfolded proteins directly 45, 46 . UBE2O mediates ubiquitylation without a separate E3 ligase and, in reticulocytes, mediates the removal of α-globin subunits that failed to assemble with β-globin in the process of haemoglobin assembly 46 . In other proteins, co-translational modifications, such as amino-terminal acetylation 47 , function as signals for UPS-mediated degradation when exposed in unassembled subunits. Chaperones also assist in the degradation of misfolded proteins by autophagy 48 . HSC70 (the constitutively expressed member of the HSP70 family) and its co-chaperone BAG3 are involved in the degradation of aggregates in a process known as chaperoneassisted selective autophagy 49, 50 . HSC70 also participates in the degradation of soluble cytosolic proteins containing a KFERQ sequence motif by chaperone-mediated autophagy in lysosomes 51, 52 and endosomal microautophagy in late endosomes and multivesicular bodies 42, 53 .
Sources of misfolded protein species
Misfolded protein species originate from multiple sources and pose a constant danger to the cell. Conformational stress conditions, such as heat stress, oxidative stress 54 or exposure to toxic agents such as cadmium 55 , may cause a subset of proteins to unfold, which increases the risk of them aggregating. In contrast to proteins with intrinsically disordered regions, some of which inherently possess a great capacity for toxic aggregation, this unfolding step is necessary for the aggregation www.nature.com/nrm of globular proteins such as superoxide dismutase 1, which is associated with amyotrophic lateral sclerosis (ALS) 56 . Moreover, the protein synthesis and folding process is imperfect despite the presence of abundant chaperone systems, and it has been estimated that 5-30% of all newly synthesized proteins do not properly fold and need to be targeted for immediate degradation [57] [58] [59] . It is well established that folding efficiencies are substantially lower for specific proteins, such as the cystic fibrosis transmembrane conductance regulator (CFTR) and other multipass membrane proteins. In the case of CFTR, only ~25% of synthesized protein matures into the functional chloride channel, with disease-causing mutations reducing folding efficiency even further 60, 61 . For some muta tions of superoxide dismutase 1 that are associated with familial ALS, it has been shown that the initial folding steps are delayed, generating aggregation-prone folding intermediates 62 . Defective mRNAs are another notable source of aberrant protein products. Translation of mRNAs lacking a stop codon (so-called non-stop mRNAs arising from truncation or premature cleavage of the transcript and polyadenylation) results in ribosome-stalled polypeptide chains that are folding incompetent. These chains must be removed by ribosome quality control (RQC) machinery and proteasomal degradation 63 (see box 1) to avoid aggregation [64] [65] [66] . The importance of the RQC pathway is exemplified by the fact that its failure is associated with age-dependent neurodegeneration in a mouse model 67 . Likewise, tRNA availability may limit translation rates, resulting in protein aggregation, perhaps by increasing the likelihood of misreading or frameshifts or by increasing the risk that nascent chains occupy non-productive folding intermediates 68 . Inefficient import into the target organelles, for example, into mitochondria or the ER, will cause cytosolic accumulation of these proteins and constitutes another cause of proteotoxicity 69 . Many secretory proteins require the oxidizing environment of the ER for disulfide bond formation and consequently fail to fold in the reducing environment of the cytosol, generating potentially toxic species that need to be eliminated 70 .
Pathology of protein aggregates
More than 100 years ago, Alois Alzheimer described the appearance of protein plaques in the cerebral cortex of a 56-year-old patient 71 . Protein aggregate deposits in fibrillar (amyloid-like) form are now widely recognized as hallmarks of many neurodegenerative diseases and other mostly age-dependent pathologies, such as type II diabetes 72, 73 . It is generally believed that aggregate formation confers on the disease protein a toxic property ('toxic gain of function'); this contrasts with other diseases associated with protein misfolding for which the defect is often due to mutations that cause loss of function 74 . Cystic fibrosis is one of the most prominent examples of this latter group of diseases 75 .
Formation of pathological aggregates. Two primary stable forms of protein aggregate can be distinguished: amyloid fibrils and amorphous aggregates. Amyloid fibrils are characterized by an ordered cross-β structure, in which parallel or anti-parallel β-strands run perpendicular to the long fibril axis, and have distinct tinctorial properties [76] [77] [78] [79] . By contrast, amorphous aggregates, although also rich in β-structure, lack long-range order and fibrillar morphology. Amorphous aggregates are common to many proteins, and pathological aggregation is mostly associated with the formation of amyloids, but amorphous aggregation can also be linked to disease (a prominent example is cataract, which is associated with amorphous aggregates of α-crystallin).
Fibrils form via a nucleation-dependent polymerization pathway, which includes various intermediate soluble, oligomeric and protofibrillar states that are structurally less ordered than the fibrils and are thought to contribute strongly to toxicity. Fibril formation is often associated with a long lag time 80 . Several possible microscopic processes underlie the characteristic sigmoidal aggregation curves: primary nucleation of monomers in solution or on surfaces, elongation of fibrils through monomer addition to fibril ends, secondary nucleation of oligomers on the surface of already existing fibrils and fibril breakage 73, 81, 82 . Preformed fibrils or fragments of them may function as seeds for new, accelerated fibril formation. In addition, prion-like cell-to-cell propagation of such seeds is thought to cause spreading of aggregates in the brains of patients with Alzheimer disease or Parkinson disease [83] [84] [85] [86] . Notably, amyloid fibrils are not necessarily harmful to cells, as demonstrated by an increasing list of amyloids not related to disease that have various cellular functions 87 , including the curli fibrils of Escherichia coli that mediate the attachment of virulent bacteria to epithelial
Box 1 | Ribosomal quality control
Cells constantly produce faulty mRNA molecules, including truncated and prematurely polyadenylated forms that lack a stop codon (non-stop mRNA). Their translation results in aberrant nascent polypeptide chains that stall on the ribosome and must be degraded by a specialized ribosomal quality control (RQC) machinery 63, 229 . Ribosome stalling and RQC can also occur because of inhibitory mRNA stem-loop structures and suboptimal decoding of mRNA codons at the ribosome (no-go mRNAs). In the case of premature polyadenylation, translation of the poly(A) tail generates a carboxy-terminal polylysine tract, which may aggravate stalling in the negatively charged ribosomal tunnel.
In the yeast Saccharomyces cerevisiae, the RQC machinery comprises the e3 ubiquitin ligase listerin (ltn1), the nucleotide-binding protein Rqc2 (NemF in humans), Rqc1 (TCF25 in humans) and the AAA + ATPase Cdc48 (vCP or P97 in humans) and its cofactors 230, 231 . The stalled ribosome is recognized by the ubiquitin ligase Hel2 (ZNF598 in mammals) and splitting factors. Rqc2 binds the 60S subunit containing the stalled nascent chain and recruits ltn1. Rqc2 elongates the stalled chain in an mRNAindependent fashion by adding alanine and threonine residues to its carboxy terminus (so-called CAT tails) 232, 233 . ltn1 ubiquitylates the stalled chain for recognition and extraction by Cdc48 (dependent on Rqc1), followed by proteasomal degradation. Deletion of ltn1 causes stalled proteins to aggregate in a manner mediated by their CAT tails 64, 65, 234 . In yeast cells, these aggregates cause impairment of the proteostasis network by sequestering chaperone regulators, such as the Hsp40 protein Sis1
(ReFs 64, 65 ). mutation of lTN1 causes neurodegeneration in a mouse model 67 . Amino-terminal signal sequences of stalled nascent chains can drive their import into mitochondria or the endoplasmic reticulum. The cytosolic protein vms1 is an additional RQC component protecting mitochondria against the toxic effects of CAT-tail aggregates 235 . vms1 binds to the outer mitochondrial membrane 236 and antagonizes the function of Rqc2 on 60S ribosomes at the outer mitochondrial membrane 235 by acting as a peptidyl-tRNA hydrolase 237, 238 . As a result, stalled chains are released for import into the mitochondria before CAT tails can be synthesized. surfaces 88 and the mammalian premelanosome protein PMEL17, which provides a template for melanin polymerization 89 . Rather, toxicity arises when various aggregation intermediate states, primarily soluble oligomers (non-fibrillar or protofibrillar species), are formed during the process of fibril assembly. In support of this view, 'functional amyloids' appear to have been optimized in evolution such that their formation is associated with a minimal number of aggregation intermediates 90, 91 . How this is achieved is a subject of ongoing research. Soluble oligomers are thought to display characteristic structural properties independent of sequence 78, 92 . They are structurally dynamic and expose hydrophobic amino acid residues and unpaired β-strands to the solvent, features that are largely buried in ordered fibrils. These properties of oligomers confer a high degree of interactivity with cellular proteins and membranes [93] [94] [95] [96] . However, amyloid fibrils and amorphous aggregates may also engage in aberrant interactions with proteins and membranes. The exact differences in the amount and nature of the interactions of these various aggregate species remain to be established.
A special case of disease-relevant protein aggregation involves liquid-liquid phase separation of certain proteins containing low-complexity domains, often with prion-like properties [97] [98] [99] . In this process, a homogeneous solution of molecules spontaneously separates ('demixes') into two coexisting liquid phases -a condensed phase (a membrane-free droplet-like compartment) and a depleted phase (the bulk solution). The interface of the condensed droplet forms a boundary that enables the selective passage of some molecules but not others. These phase-separated assemblies provide a general regulatory mechanism to compartmentalize biochemical reactions within cells, enhancing biological reactions or sequestering factors that are temporarily not required 99, 100 . Notably, some of these assemblies, over time, undergo a maturation process, which involves a liquid-to-solid phase transition with the concomitant formation of structures reminiscent of pathological aggregates. These processes can be accelerated by mutations, post-translational modifications, changes in the properties of the solution (salt concentration) and/or metabolic state or in response to increasing molecular concentration 98, 101, 102 . Thus, phase separation could promote increased rates of nucleation and/or growth of amyloid-like fibres. A prominent example is the aggregation of the predominantly nuclear RNA-binding proteins FUS and TDP43 in the cytosol, mutations of which are associated with ALS 102, 103 . Agerelated changes in the proteome (changes in the balance between synthesis and degradation and a decline in folding capacity; see also below) and metabolome (changes in the local micro environment) can lead to aberrant phase transitions that may be key drivers of ageing and disease 104 .
Mechanisms of aggregate toxicity. How aggregates cause toxicity, cellular dysfunction and eventual death is only partially understood. A large body of evidence points to multiple mechanisms acting in parallel, with specific modes of toxic function being more pronounced in certain disease proteins and cell types. Two principal activities at the cellular level can be distinguished: damaging effects on lipid membranes and aberrant interactions with macromolecules, primarily soluble or membrane-associated proteins and RNA molecules (Fig. 2) . Experiments in cell culture and studies with model lipid membranes indicate that soluble oligomers (approximate size range 20-60 molecules) have the ability to disrupt the integrity of membrane structures in the neuronal synapse and other cellular locations by forming pore-like structures [105] [106] [107] (Fig. 2a) . Fibrils, although exposing fewer hydrophobic surfaces than oligomers, nevertheless may have the capacity to deform or even pierce endomembranes, as shown in vitro 79, 108 and suggested by recent observations of aggregate deposits in situ by cryo-electron tomography 109 ( Fig. 2a) .
Low-complexity domains
sequences of amino acids with little diversity that are often intrinsically unstructured. 105, 106 (left panel), while fibrillar aggregates can interact with and deform membranes 108, 109 (right panel). b | Chronic expression of aberrantly folded proteins caused by disease, ageing or external stress reduces proteostasis capacity by sequestering or otherwise inhibiting proteostasis network components, including (but not limited to) proteasomes 126, 127 , chaperones 119, 120 , nucleocytoplasmic transport factors 111 and factors necessary to mount a successful stress response 115, 121 . This reduced capacity will result in further misfolding and aggregation of endogenous proteins. These additional misfolded species in turn engage the proteostasis network , thereby further reducing available proteostasis capacity and driving a positive feedback loop that eventually leads to proteostasis collapse.
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The other well-supported mechanism of proteotoxicity relates to the ability of aggregates to engage in aberrant interactions with multiple cellular proteins (Fig. 2b) , such as nucleocytoplasmic transport factors, ribonucleoproteins and other proteins with key functions 96, [110] [111] [112] [113] [114] . The proteins bound by the aggregates tend to be metastable and characteristically contain intrinsically disordered regions or low-complexity domains 96, 111, [115] [116] [117] [118] . According to recent studies, these interactions are primarily initiated by protein oligomers and are first dynamic in nature but may result in the stable sequestration of target molecules in insoluble aggregate deposits 96, 114, 115 . Importantly, owing to their ability to recognize and bind misfolded proteins, certain chaperones and other proteostasis components are also prone to sequestration by aggregates. As a result, chaperones and regulatory chaperone cofactors, such as HSC70 and certain HSP40 regulators of the HSP70 system, are substantially depleted from the soluble, active pool, which has a negative impact on the proteostasis network by reducing its overall strength and thereby contributes to further aggregate accumulation 64, 119, 120 . Sequestration of regulatory proteostasis network components also impedes the capacity of cells to induce an effective heat shock response 115, 121 . Interestingly, the sustained presence of misfolded proteins may lead to a chronic stress response activation that is ineffective in preventing aggregation. This state has been referred to as a maladaptive stress response and has been shown to impact protein folding and exacerbate disease pathology 122 . Expression of aggregation-prone proteins has also been shown to impair protein degradation via autophagy 123 and the UPS [124] [125] [126] [127] . Indeed, some disease aggregates, such as those formed by C9orf72-encoded glycine-alanine dipeptide repeat proteins associated with ALS 126 , display a remarkably strong association with proteasome complexes, reflecting an (apparently unproductive) attempt of the UPS to degrade aggregate material.
Overall, protein aggregates have the capacity to interfere with the proper function of the proteostasis network. The resulting reduction of available proteostasis network capacity increases protein misfolding, setting in motion a vicious feedforward cycle that may lead to proteostasis collapse 128 (Fig. 2b) .
Means of counteracting proteotoxicity
The functional proteostasis network antagonizes the build-up of aggregates or strives to neutralize their toxic effects. This may be achieved by fundamentally different strategies. Prevention of aggregation is a primary function of molecular chaperones and is achieved by binding of aggregation-prone folding intermediates, followed by their refolding or degradation. Pre-existing aggregates may be shielded by chaperones to block harmful inter actions or may be removed by disaggregation or autophagy. Alternatively, toxic aggregate species, such as soluble oligomeric species, may be actively converted into large inclusion bodies (containing amorphous or fibrillar aggregates), thereby reducing their reactive surfaces for toxic interactions with cellular components (Fig. 3) .
Chaperone-mediated prevention of amyloid formation. Chaperone systems interfere with amyloid-like aggregation at different kinetic phases of fibril formation (Fig. 3) . As a result, aggregation may be completely prevented, or the equilibrium between aggregate species may be changed 129 . Consistent with its central role in the chaperone network, the HSP70-HSP40 system has been shown to inhibit primary nucleation of fibril assembly and fibril elongation of polyglutamine expansion proteins such as huntingtin (encoded by HTT, mutants of which cause Huntington disease), α-synuclein (associated with Parkinson disease) and other neurodegenerative disease proteins [130] [131] [132] [133] [134] . HSP40 components have an important role in this process and recruit HSP70 to aggregationprone proteins 134, 135 . The chaperones perform this function by interacting with hydrophobic sequence elements that support aggregation of these disease proteins. The cylindrical chaperonin TRiC (also known as CCT) also acts to inhibit aggregation of various disease proteins 129, 136, 137 and has been shown to specifically prevent the formation of toxic oligomers of huntingtin in favour of larger, less toxic oligomers 129 . Other chaperones, such as the small bRiCHos domain, may coat the surface of fibrils and inhibit secondary nucleation 138 , thereby interfering with the production of toxic oligomers.
Chaperone-mediated disaggregation. Interfering with the production of disease protein halts disease progression and allows for the dissociation of pre-existing aggregates, as shown in mouse models of Huntington disease 139, 140 . Indeed, cells contain specialized chaperone machineries that can dissociate aggregates in an ATPdependent process. In yeast and other fungi, AAA + chaperones of the Hsp100 family mediate protein disaggregation in concert with Hsp70 and Hsp40 (ReFs 141, 142 ).
In metazoans, which lack HSP100 family members, a network of chaperones including HSP70 and the nucleotide exchange factor HSP110 (an HSP70 homologue) mediates protein disaggregation 143, 144 . Notably, disaggregation entails the danger of generating oligomeric, potentially toxic, protein species and therefore must be coupled to the degradation of aggregate material via the UPS or the autophagosomal-lysosomal pathway (Fig. 3) . How this timely degradation is achieved remains to be investigated.
Aggregate sequestration. In conditions of limited proteostasis capacity, cells may reduce aggregate load by actively sequestering smaller aggregates into larger deposits (Fig. 3) . Upon heat stress, the chaperone Hsp42, a sHSP, mediates the rapid concentration of misfolded proteins into small cytosolic aggregate foci (also referred to as Q bodies) [145] [146] [147] [148] , which may give rise to larger inclusions. Interestingly, this 'aggregase' function depends on a prion-like, intrinsically disordered sequence of Hsp42 (ReF. 149 ). A related protein, Btn2, fulfils a similar role in the nucleus 146 . Association of sHSPs with amor phous aggregate deposits is frequently observed and may shield aggregate surfaces that are available for interactions and facilitate subsequent disaggregation 150 . Inclusion bodies are actively formed in yeast in the vicinity of the vacuole and the nucleus, as well as in the nucleus 146, 151 . Mammalian cells concentrate aggregated proteins in so-called aggresomes at the microtubuleorganizing centre in an ATP-dependent and microtubuledependent process 152 . Inclusion bodies may function as a sink to lower the level of small diffusible oligomers and thereby reduce the reactive surface and the number of bound chaperones, consistent with the reduced capacity of aggregate material in inclusion bodies to engage in aberrant interactions 96, 114 . Indeed, the presence of inclusion bodies correlates with improved cell survival in cellular models of neurodegenerative disease 153 . Concentration of aggregates in an inclusion body can also facilitate the asymmetrical inheritance of damaged proteins in dividing cells (Fig. 3) . This process generates one daughter cell that contains the majority of the aggregated proteins and a second 'rejuvenated' daughter 154 . The lack of cell division in postmitotic cells such as neurons can therefore help explain why these cells are especially vulnerable to pathologies associated with protein aggregation.
Directing aggregation-prone material to specific organelles has been suggested as yet another strategy to reduce toxicity 155, 156 (Fig. 3) . For example, the aggregates of specific disease proteins have been found to be more toxic in the cytosol than in the nucleus (and vice versa), and a recent report suggested that, upon heat stress, certain misfolded proteins can be detected inside mitochondria, although they lack mitochondrial targeting sequences 157 . The physiological importance and the underlying mechanism of this observation remain unclear, but it is noteworthy that mitochondria and the ER have a higher tolerance for the presence of aggregation-prone proteins than the cytosol does; this is presumably due to the increased capacity of these compartments to maintain aggregation-prone disease proteins in a soluble state owing to the presence of compartment-specific chaperone systems 158, 159 .
age-dependent proteostasis decline
The age-dependent decline in the ability of cells to maintain a functional proteome is regarded as a major driver of age-related cellular dysfunction and degenerative diseases [2] [3] [4] 160, 161 . The biological reasons why the proteostasis network deteriorates are complex but probably relate to a lack of evolutionary pressure for proteome maintenance beyond the point when organisms have produced progeny and passed their genome to the next generation. Chaperones function to prevent aggregate formation, disassemble pre-existing aggregates and facilitate the refolding of disaggregated proteins to the native state, or conformationally remodel toxic aggregates into less-toxic or non-toxic forms. Notably , chaperone-mediated disaggregation of more complex aggregates such as amyloid fibres is linked to the generation of smaller oligomers, which are potentially more toxic than the larger aggregates. Thus, disassembly should be coupled to efficient degradation of abnormal protein species. Alternatively , the interactive surface area of the aggregate can be reduced by concentrating oligomeric species into large inclusions, which may contain fibrillar or amorphous aggregate material, or by shielding the aggregate surface with chaperones such as small heat shock proteins (sHSPs). Aggregation-prone proteins can also be sequestered in subcellular locations, such as the nucleus or mitochondria, which show a higher tolerance for aggregation-prone proteins than the cytosol does. In dividing cells, it is also possible to retain the aggregated proteins in only one of the daughter cells through asymmetrical cell division, thereby generating a rejuvenated daughter cell.
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In model organisms such as C. elegans, a controlled ageing programme is thought to allocate organismal resources to reproduction rather than proteome maintenance 162 , and most genetic manipulations that extend lifespan and improve proteostasis are associated with reduced fecundity (see box 2).
Recent systemic proteome analyses throughout the lifespan of C. elegans provided insight into agedependent changes in proteome composition [163] [164] [165] [166] [167] . Large-scale proteome profiling of ~5,000 different proteins revealed extensive proteome remodelling and the development of severe proteome imbalance during ageing, characterized by extensive changes in the abundance of proteins 166 . Approximately one-third of the quantified proteins were found to increase or decrease in abundance by at least twofold after day 6 of adulthood. These global changes are thought to be caused (at least in part) by dysregulation in microRNA-mediated post-transcriptional gene regulation 166, 168 . This agedependent proteome remodelling was substantially less pronounced in long-lived daf-2 mutant worms defective in insulin/insulin-like growth factor (IGF) signalling (see box 2), which is indicative of an improved capacity of the proteostasis network. The extensive proteome remodelling observed during ageing in C. elegans differs from observations of tissues in aged mice where only minor proteomic changes were detected with a similar experimental approach 169 . Thus, mammals appear to devote greater resources to maintaining proteome balance, limiting age-dependent cell-type and organelle-specific proteome changes 170 . A hallmark of the ageing proteome is the loss of protein solubility and the accumulation of aggregates. C. elegans has been used extensively as a model to study this process 163, 164, 166 . A recent quantification of ~2,100 aggregating proteins 166 tested the view that proteins have been optimized in evolution to maintain solubility at their physiological concentration (before age-dependent proteome deregulation) but aggregate when exceeding that concentration 171 (referred to as critical concentration). The analysis confirmed that proteins of low abundance tend to have greater aggregation propensities during Hormesis an adaptive response of an organism or biological system towards a low dose of a toxic agent or physical conditions (for example, reactive oxygen radicals or thermal stress) that preconditions the organism to tolerate a higher dose of the same toxic agent.
Critical concentration
The concentration up to which a protein remains soluble; exceeding this concentration results in insolubility and aggregation.
Box 2 | Signalling pathways that modulate ageing and proteostasis
Studies in model organisms showed that ageing and longevity are genetically regulated. lifespan extension is achieved in three main ways: inhibition of the insulin/insulin-like growth factor 1 (IGF1) signalling (IIS) pathway, reduction of food intake or attenuation of the mitochondrial electron transport chain (eTC).
Insulin/insulin-like growth factor 1 signalling Identified in Caenorhabditis elegans as a lifespan-regulating signalling pathway 183 , IIS is conserved from worms to human and controls ageing, stress resistance and proteostasis by negatively regulating the nuclear translocation of the transcription factors DAF-16 (forkhead box o proteins (FoXos) in mammals), HSF-1 (heat shock factor 1 (HSF1 in mammals)) and SKN-1 (nuclear respiration factor 2 (NRF2) in mammals), which induce the expression of protective stress response pathways, such as the upregulation of chaperones and proteins protecting against oxidative damage (see the figure) . Binding of insulin or insulinlike ligands to the DAF-2 receptor activates its tyrosine kinase activity and recruits AGe-1 (PI3K in mammals). This ultimately leads to phosphorylation of the downstream transcription factors, preventing their translocation into the nucleus. In contrast, reduced IIS in worms with mutations in daf-2 or age-1 blocks this phosphorylation, enabling entry of DAF-16, HSF-1 and SKN-1 into the nucleus for induction of genes required for extending lifespan, promoting stress resistance and enhancing proteostasis.
Dietary restriction
Dietary restriction (that is, reduced food intake without malnutrition) is the most robust intervention to increase lifespan and delay age-related dysfunction in organisms from yeast to mammals. In C. elegans, various cellular energy sensors, such as AmP-activated protein kinase (AmPK) and target of rapamycin (ToR), mediate the beneficial effects of dietary restriction, supporting activation of PHA-4 (FoXoA in mammals), DAF-16, HSF-1 and SKN-1. In addition, dietary restriction has been shown to induce autophagy.
Mitochondrial electron transport chain mutations affecting the mitochondrial eTC increase the lifespan in C. elegans [239] [240] [241] . Such mutations cause (partial) uncoupling of the eTC and production of reactive oxygen species, which upregulates the mitochondrial unfolded protein response (uPR mito ). As long as production of reactive oxygen species is limited, this mechanism leads to a beneficial effect (hormesis). Details of the signalling pathways involved are just emerging: mitochondrial stress causes chromatin remodelling in C. elegans, which is required for activation of uPR mito and stress-induced longevity. Two conserved histone lysine demethylases function as positive regulators of the eTC longevity pathway [241] [242] [243] . Recently, it has been reported that mild mitochondrial stress is sufficient to maintain proteostasis, healthspan and stress resistance in an HSF1-dependent manner 244 , suggesting that the eTC is a central regulator of cytosolic proteostasis. NATuRe RevIewS | MoleCulaR Cell BIology ageing than abundant proteins have. Nevertheless, highly abundant proteins were found to predominantly contribute to total aggregate load despite their greater intrinsic solubility 166 . Apparently, the solubility of abundant proteins is insufficient to protect them from age-dependent aggregation because the proteome and proteostasis network changes associated with ageing (see the following paragraph) result in these proteins eventually exceeding the critical concentration, a phenomenon referred to as supersaturation 171, 172 . During ageing, the proteostasis network becomes increasingly burdened by increasing loads of misfolded proteins and proteins that have been damaged by oxidative stress 173 , particularly in nondividing, long-lived cells such as neurons 9, 174 . In addition, at least in human brain, the expression of ATP-dependent chaperones is repressed during ageing, which may further promote protein misfolding and aggregation 175 ( Fig. 2b) . Once the capacity of the proteostasis network drops below a critical level, aggregation-prone proteins can no longer be maintained in a soluble state. As shown in cellular and organismal models, this threshold is lowered in the presence of additional forms of stress, such as proteasome inhibition 176 , or in the presence of mutations that structurally destabilize specific proteins and promote misfolding 10, 177 . The additional pressure on the proteostasis network causes further protein aggregation in a positive feedback loop 125, 128 (Fig. 2b) .
Notably, stem cells are more resistant to agedependent proteostasis network decline than differentiated cells are. It has been demonstrated that human embryonic stem cells exhibit elevated levels of proteasome activity for degrading misfolded proteins 178 . Furthermore, human pluripotent stem cells support the efficient assembly of the TRiC chaperonin complex, apparently by enhancing the expression of one of its eight subunits, CCT8 179 , which limits complex assembly when present in substoichiometric amounts. Asymmetrical division of stem cells might also have a role in maintaining a balanced proteome, with the differentiating cell inheriting the damaged proteins [180] [181] [182] . These mechanisms may contribute to the maintenance of stem cells throughout the animal lifespan. Interestingly, the neural stem cell pool in the brain of adult mice comprises quiescent and activated populations with differences in their proteostasis networks. While activated stem cells have active proteasomes, quiescent stem cells were recently shown to rely on large lysosomes for aggregate removal. Lysosomal damage accrued during ageing may reduce the ability of quiescent cells to dispose of aggregates and to activate 181 .
Pro-longevity adaptations
Studies in model organisms including C. elegans, Drosophila melanogaster and mice indicate that the ability of the organism to maintain proteostasis correlates strongly with both lifespan and healthspan (that is, the time during which the organism maintains its functional capacity). Accordingly, adaptations in each arm of the proteostasis network (Fig. 1a) , through either genetic or environmental effects, have been shown to prolong lifespan. For example, inhibition of the insulin/IGF1 signalling pathway (daf-2 mutant in C. elegans), the major lifespan-extending manipulation in the worm 183, 184 , results in a profound upregulation of stress resistance through transcriptional activation of chaperone pathways and increased defence against oxidative stress (box 2).
Changes in protein synthesis and degradation. Protein synthesis is a primary node of proteostasis control, and its regulation is crucial for cell growth and maintenance of intracellular protein pools. Notably, with increasing age, rates of protein synthesis tend to decline 165, 185, 186 . As shown in C. elegans, the levels of both cytosolic and mitochondrial ribosomes undergo substantial reduction during ageing (Fig. 4a) , especially in the long-lived daf-2 mutant worms 166 . The decline in ribosome abundance may function as an adaptive response to the increased proteotoxic challenges that occur in ageing. Attenuating global translation reduces the production of faulty proteins, thereby easing the burden on molecular chaperones and degradation systems. Indeed, transient inhibition of translation via phosphorylation of translation initiation factor 2α (eIF2α) is an important strategy to protect cells from protein misfolding stress 187 and is prominently associated with the unfolded protein response (UPR) of the ER and the integrated stress response 31, 188 . Reduction of protein synthesis has beneficial effects, including lifespan extension in worms [189] [190] [191] [192] . An imbalance between the production of misfolded proteins and available proteasome capacity is implicated in various age-related pathologies 128, 193 , and a decline in proteasome function has been observed during ageing in model organisms in various tissues and cell types [194] [195] [196] . In C. elegans, the abundance of proteasomal subunits was found to increase with age 166 (Fig. 4a) , apparently reflecting an attempt of the organism at removing aberrant protein species. Upregulation of proteasomes was further enhanced in the daf-2 mutant.
Adaptations in the chaperone network. During human brain ageing, the expression of ATP-dependent chaperones (HSP70 and HSP60) is repressed, which may contribute to the decline in the capacity to counteract protein misfolding 175 . Notably, in C. elegans, the levels of HSP-70 and HSP-90 chaperones and their co-chaperones change only moderately during ageing 165, 166 , whereas multiple sHSPs increase dramatically (~15-fold to 60-fold), especially in the daf-2 mutant 166 , along with proteins involved in oxidative stress defence that prevent oxidative stress and the resulting protein damage 166 ( Fig. 4a) . Upregulation of sHSPs is also observed in D. melanogaster 197 , as well as in mammalian skeletal muscle 198 and brain during ageing 170 , suggesting that it is a general phenomenon.
Controlled protein aggregation.
During ageing in C. elegans, several types of sHSP were found to be highly insoluble with a high rate of accumulation in the aggregate fraction 166 ( Fig. 4b ). Similar observations have been made in vertebrate systems, including human skeletal muscle, as well as in bacteria [198] [199] [200] . The recruitment of these chaperones into the insoluble fraction may reflect a controlled attempt of the organism to sequester protein aggregates, consistent with age-dependent formation Unfolded protein response (UPR). a cellular stress response pathway that serves to increase the protein-folding capacity of the endoplasmic reticulum or the mitochondria.
Integrated stress response a conserved signalling pathway that responds to a variety of cellular conditions and attenuates protein translation via phosphorylation of translation initiation factor 2α (eiF2α).
www.nature.com/nrm of aggregates (as inclusion bodies) being a regulated, protective response to lower the pressure on the proteostasis network 166 . The age-dependent increase in the levels of sHSPs may thus reflect a shift in defence strategies from preventing aggregation to selective sequestration of dangerous protein species in aggregate deposits (Fig. 4b) . In support of this possibility, enhanced aggregation of a subset of proteins with an enrichment of unstructured regions, along with certain sHSPs, was observed in longlived daf-2 mutant worms 166 . Indeed, overexpression of a sHSP (HSP-16) is sufficient to extend the lifespan of C. elegans 201 . This hyperaggregation under control of insulin/IGF1 signalling may be a fail-safe protective mechanism to reduce the concentration of potentially harmful oligomeric aggregate species when the first-line defences to prevent aggregation -including prevention of misfolding and remodelling of misfolded proteinsfail [202] [203] [204] . These findings are consistent with the view that soluble oligomers are the major proteotoxic species in neurodegenerative diseases and that their sequestration into insoluble aggregates reduces proteotoxicity (Fig. 3) .
conclusions and perspective Proteins are essential for most cellular functions. To maintain a functional and balanced proteome, cells invest in an extensive machinery comprising molecular chaperones, proteases and other factors. While this sophisticated machinery is sufficient to fulfil its task in young and healthy individuals, its activity declines over time and, at some point, is no longer able to combat the accumulated effects of proteotoxic insults. As a consequence, ageing is associated with loss of proteome balance and widespread protein aggregation, facilitating the development of degenerative pathologies such as Alzheimer or Parkinson disease.
As shown first in a mouse model of Huntington disease, the proteostasis network is able to clear aggregates when further synthesis of mutant protein is blocked, allowing the (partial) reversal of disease phenotypes 140 . Accordingly, reducing the expression of aggregationprone proteins with antisense oligonucleotides has been shown to be beneficial, even when aggregates have already formed 139, 205 . Other approaches are the removal of toxic aggregates using specific antibodies and clearance of aggregate-antibody complexes through phagocytosis 206, 207 or the use of small-molecule kinetic stabilizers that bind the native state of disease proteins and prevent their aggregation. A successful example of this latter approach is the small molecule tafamidis that stabilizes transthyretin tetramers and prevents their dissociation, which is the rate-limiting step in transthyretin amyloidogenesis 208 . However, all these approaches are diseasespecific and, in some cases, limited to a particular protein mutation. By contrast, augmentation of the proteostasis network has the potential to provide a general means to postpone a range of age-related degenerative conditions or slow their progression 209 . Notably, germ cells and some stem cells have mastered the unlimited propagation and preservation of a healthy proteome. This would suggest that it is possible to carefully augment the proteostasis network and thereby delay the onset or slow the progression of age-dependent degenerative diseases. In principle, this may be achieved by pharmacologically modulating the transcriptional circuits that regulate the different arms of the proteostasis network 210 . Increasing organismal protein-folding capacity is one potential approach to enhance proteostasis capacity. ). Despite the increased abundance of the components of proteostasis networks, the activity of these mechanisms may nevertheless be insufficient to counteract the burden of misfolded proteins in aged wild-type animals. b | Proteome protective activity of sHSPs during ageing in wild-type and daf-2 worms. Young adult worms maintain a balanced proteome by effectively clearing misfolded proteins. Ageing is associated with proteome imbalance owing to inefficient clearance of proteins, misregulated transcription and loss of the relative stoichiometries of protein complexes 166 . This results in supersaturation 171, 172 and aggregation of a subset of proteins and the accumulation of potentially toxic oligomer species. sHSPs increase in abundance during ageing and have a protective role by sequestering soluble oligomers into insoluble inclusions and by shielding interactive aggregate surfaces. The stronger upregulation of sHSPs in the daf-2 mutant than in the wild type enables more effective sequestration of potentially dangerous aggregate material, maintaining proteome balance as the animals age.
Expression of individual chaperones and co-chaperones or pharmacological activation of stress responses (heat shock response or UPR) has been demonstrated to ameliorate phenotypes associated with protein aggregation in cellular and organismal models, including yeast, C. elegans, D. melanogaster, mammalian cells and mice 129, 130, [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] . Furthermore, the exogenous delivery of a recombinant fragment of the chaperonin TRiC was shown to modulate cellular phenotypes of Huntington disease 221 . Downregulating protein synthesis, thereby reducing the pressure on the chaperone machinery, is another strategy to improve proteome quality, mimicking the attenuation of translation associated with the activation of UPR pathways 187, 222 . Enhancing the cellular capacity to dispose of toxic protein species by upregulating proteolytic activity is yet another way to boost the cellular capacity to maintain proteostasis. Small-molecule inducers of autophagy, such as rapamycin (and its analogues), show benefits in animal models of different neurodegenerative diseases 223 .
Accelerated degradation of proteasomal substrates may result from inhibition of deubiquitylating enzymes 224 or upregulation of proteasome assembly 178, 225 . Notably, however, modulation of the proteostasis network comes at a cost, as it has been pointed out that increasing proteostasis capacity and stress resistance may favour cancer progression 226 . This pro-tumorigenic effect stems from the fact that cancer cell proliferation depends on the function of multiple mutant proteins that require stabilization by the chaperone network 227 . Accordingly, inhibition of chaperones such as HSP90 may be beneficial in the treatment of certain cancers 228 . Overall, as our understanding of cellular and organismal proteostasis networks improves further, there is justified hope that this knowledge will result in actual benefits to patients with degenerative diseases resulting from protein aggregation and may provide strategies to increase the human healthspan. 
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